metricas

Vacunas

Sugerencias
Vacunas Lo más citado
Información de la revista

Lo más citado

Datos disponibles en articúlos publicados a partir del año 2014

6
Bibliometric analysis of circular RNA cancer vaccines and their emerging impact
Uddalak Das, Soupayan Banerjee, Meghna Sarkar
Vacunas. 2025;26:500391
6
3
COVID-19 story: Entry and immune response
Ali Mohammed Ashraf, Marwan Y. Al-Maqtoofi, Ahmed A. Burghal
Vacunas. 2025;26:100380
3
3
A narrative review on the white spot syndrome virus and the perspective of vaccine development
Susithra Priyadarshni Mugunthan, Nivetha Loganathan, Balamurugan Shanmugaraj, Harish Mani Chandra
Vacunas. 2025;26:100382
3
2
Development of a novel multi-epitope vaccine candidate for Marburg virus applying advanced immunoinformatics strategies: A computational analysis
Md. Nafij Mashrur, M. Nazmul Hoque, Soharth Hasnat, Sakhawat Hossen Saikat, Md. Mehedi Hasan, Faria Khan Hridy, Nurul Amin Rani, Fardous Mohammad Safiul Azam
Vacunas. 2025;26:500461
2
2
An overview of anticancer roles of nanoparticles synthesized by microbes
A. Hosseingholian, P. Jafari, A. Abedini, H. Jooya, J.D. Gross, M. Beyranvand, A. Samadi, S. Khoshnood
Vacunas. 2025;26:500388
2
1
Would senior citizens get vaccinated against RSV? Exploratory analysis using a novel survey instrument
Mohammad Abu-Ghosh, Dareen Saleh, Joud Al-Haddad, Leen Sabbah, Raghad Alnusairat, Muna Barakat, Malik Sallam
Vacunas. 2025;26:100384
1
Acceso a texto completo
Artículo abierto